Based in Germany In response to a positive test for Klebsiella oxytoca, a bacterium that is naturally present in the mouth, nose, and intestinal tract, Henkel voluntarily recalled 1,068 units of their Tec Italy Shampoo for “dry and damaged hair.”
Although the bacteria is not harmful within the intestinal system, if it spreads to other parts of the body, such as the bloodstream, it can kill 10–20% of patients.
The FDA claims that distributors C&R Beauty, Caesar’s Professional items Inc., and Vero Beauty Distributors received recalled items from a Mexican plant.
The impacted goods were sold directly to salons, where clients could buy them, despite Tec Italy being a well-known brand that is available at retailers like Walmart, Target, and Amazon.
The number of salons that offered the goods and the number of customers who bought them are unknown.
So yet, no illnesses have been reported.
Products with lot code 1G27542266 and an expiration date of May 27, 2027, are affected.
The recall was classified as Class II, which denotes “a situation where the probability of serious adverse health consequences is remote or where use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences.”
The recall follows the January recall of Tonico Shampoo from Tec Italy for possible E. coli contamination.
When Klebsiella oxytoca remains in the intestines, it is regarded as a healthy bacterium.
However, it can cause pneumonia-like symptoms including fever, chills, shortness of breath, and cough if it enters the body through other channels, such as the bloodstream.
Additionally, patients may have lower abdomen pain, vomiting, and pain when urinating.
The majority of patients recover with antibiotics or rest, but those with compromised immune systems or long-term medical issues may experience sepsis and other blood or lung infections.
The fatality rate varies because Klebsiella oxytoca infections are uncommon, affecting only 100 Americans annually.
The number of infections that move to the bloodstream is unknown.
Ten to twenty percent of individuals are thought to die from a Klebsiella oxytoca infection.
The FDA has not provided detailed instructions on how to dispose of impacted products.
